REQUEST A DEMO
Total
USD $0.00
Search more companies

Samjin Pharmaceutical Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Samjin Pharmaceutical Co.,Ltd. Profile Updated: March 24, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Samjin Pharmaceutical Co.,Ltd. is an enterprise in South Korea, with the main office in Seoul. The enterprise currently operates in the Pharmaceutical and Medicine Manufacturing sector. It was first established on April 18, 1968. There are currently 501 - 1,000 (2025) people employed by Samjin Pharmaceutical Co.,Ltd.. In 2024, the company reported a net sales revenue increase of 5.55%. Its’ total assets recorded a growth of 1.25%. The net profit margin of Samjin Pharmaceutical Co.,Ltd. increased by 5.66% in 2024.

Headquarters
338-8 Seogyo-Dong, Mapoh-Gu
Seoul; Seoul; Postal Code: 121-739

Contact Details: Purchase the Samjin Pharmaceutical Co.,Ltd. report to view the information.

Website: http://www.samjinpharm.co.kr

Basic Information
Total Employees:
Purchase the Samjin Pharmaceutical Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Samjin Pharmaceutical Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Samjin Pharmaceutical Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Samjin Pharmaceutical Co.,Ltd. report to view the information.
Incorporation Date:
April 18, 1968
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
President
Purchase this report to view the information.
President
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
12.09%
Purchase this report to view the information.
0.66%
Subsidiaries
한국제약협동조합
4.29%
제이티비씨
0.52%
얼머스Global Health Care 투자조합
Company Performance
Financial values in the chart are available after Samjin Pharmaceutical Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
5.55%
Total Operating Revenue
13.1%
Operating Profit
147.54%
EBITDA
89.35%
Net Profit/Loss for the Period
90.32%
Total Assets
1.25%
Total Equity
-1.4%
Operating Profit Margin
9.21%
Net Profit Margin
5.66%
Return on Equity (ROE)
7.22%
Debt / Equity
1.7%
Quick Ratio
-0.04%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?